Durable therapeutic gain despite competing mortality in long-term follow-up of a randomized hyperfractionated radiotherapy trial for locally advanced head and neck cancer
Sign Up to like & getrecommendations! Published in 2020 at "Clinical and Translational Radiation Oncology"
DOI: 10.1016/j.ctro.2020.01.003
Abstract: Highlights • Hyperfractionated RT with augmented dose provides durable enhanced disease control.• Late toxicity is unchanged with higher optimal doses using smaller fraction sizes.• Hyperfractionation improves overall survival but mortality profile evolves over time.• Altered… read more here.
Keywords: competing mortality; durable therapeutic; mortality; despite competing ... See more keywords
Only
Sign Up to like & getrecommendations! Published in 2018 at "European urology focus"
DOI: 10.1016/j.euf.2018.01.019
Abstract: In the Prostate Cancer Intervention Versus Observation Trial (PIVOT), surgery was not associated with lower mortality compared with observation. However, the high competing mortality rate of approximately 33% after 10 yr among the PIVOT study… read more here.
Keywords: competing mortality; mortality; mortality rate; pivot ... See more keywords
PD13-03 COMPETING MORTALITY RISKS IN ELDERLY MEN WITH PROSTATE CANCER IN THE UNITED STATES
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Urology"
DOI: 10.1097/ju.0000000000000847.03
Abstract: INTRODUCTION AND OBJECTIVE:The natural history of prostate cancer (PC) in men of > 70 years of age is not well defined. Although the current recommendation for PC screening is limited to 70 years o... read more here.
Keywords: competing mortality; mortality risks; pd13 competing; cancer ... See more keywords